Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
Open Access
- 30 August 2021
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 143, 112095
- https://doi.org/10.1016/j.biopha.2021.112095
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- RAS signaling pathways, mutations and their role in colorectal cancerWorld Journal of Gastrointestinal Oncology, 2013
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- Gabedit—A graphical user interface for computational chemistry softwaresJournal of Computational Chemistry, 2010
- Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transportersPharmacology & Therapeutics, 2010
- Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species TransmissionJournal of Virology, 2010
- Role of HIF-1α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Just the Beginning: Novel Functions for Angiotensin-Converting EnzymesCurrent Biology, 2002
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002